Silexion Therapeutics Corp (NASDAQ:SLXN) concluded the trading at $3.14 on Wednesday, January 29 with a rise of 132.59% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $1.35 and 5Y monthly beta was reading -0.111 with its price kept floating in the range of $1.84 and $3.45 on the day. Considering stock’s 52-week price range provides that SLXN hit a high price of $122.02 and saw its price falling to a low level of $0.57 during that period. Over a period of past 1-month, stock came adding 41.44% in its value.
With its current market valuation of $12.54 million, Silexion Therapeutics Corp is set to declare its quarterly results in February. Analysts are in estimates of 0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to 0 for current year with estimates of that growing to 0 in next year.
Digging deeper we become aware of the PEG ratio of the SLXN stock which is currently positioned at 0. It further provides that stock’s current price level is 98.97% away from its 20-day simple moving average and is 40.04% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 66.84 while volatility remained at 37.14% over the past week which changes to 20.58% when measuring it over the past month. Beta is valued at -0.04, while measure of average true range or ATR is currently at 0.47.
Having a second look at Silexion Therapeutics Corp (NASDAQ:SLXN) provides that stock’s average daily trading volume for 3 months was 5.19 million, while it jumped to 26320330 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 4.00 million.
The percentage of outstanding shares held by the insiders is 47.50% while it is 11.73% for the institutional holders. The figures also indicate that as of 2024-11-15, number of stock’s short shares was 35842.0 which implies a short ratio of 0.23. This shows up a 308.00 of Short Interest in company’s outstanding shares on the day. In November the standing of shares short improved as it was 9885.0 in the previous month. Addition of 56.22% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
